LIFEZONE METALS LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.2 USD | +4.05% |
|
+8.11% | -20.35% |
| 05-13 | Wall Street Set to Open Higher Monday as Investors Look Toward Key Inflation Figures | MT |
| 05-13 | Earnings Flash (LZM) LIFEZONE METALS Reports Q1 Revenue $41,389 | MT |
Valuation
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Capitalization 1 | 372 | 706.9 | 576 | - | - |
| Enterprise Value (EV) 1 | 372 | 657.5 | 468.1 | 518.1 | 518.1 |
| P/E ratio | -0.27 x | -1.69 x | -60 x | -62.6 x | 103 x |
| Yield | - | - | - | - | - |
| Capitalization / Revenue | - | 478 x | 2,787 x | 366 x | 190 x |
| EV / Revenue | - | 445 x | 2,265 x | 329 x | 171 x |
| EV / EBITDA | - | -1.81 x | -51.3 x | -46.1 x | -50.5 x |
| EV / FCF | - | -8.32 x | -11.4 x | - | - |
| FCF Yield | - | -12% | -8.76% | - | - |
| Price to Book | - | - | - | - | - |
| Nbr of stocks (in thousands) | 35,835 | 78,194 | 79,995 | - | - |
| Reference price 2 | 10.38 | 9.040 | 7.200 | 7.200 | 7.200 |
| Announcement Date | 23-04-17 | 24-04-01 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Net sales 1 | - | 1.478 | 0.2067 | 1.572 | 3.033 |
| EBITDA 1 | - | -364.1 | -9.117 | -11.23 | -10.27 |
| EBIT 1 | - | -365.2 | -18.23 | -27.47 | -59.3 |
| Operating Margin | - | -24,710.19% | -8,822.44% | -1,746.69% | -1,954.95% |
| Earnings before Tax (EBT) 1 | - | -364.7 | -19.3 | -14.85 | -50.8 |
| Net income 1 | -23.58 | -363.9 | -13.15 | -19.1 | -51.85 |
| Net margin | - | -24,622.22% | -6,362.8% | -1,214.63% | -1,709.34% |
| EPS 2 | -38.02 | -5.340 | -0.1200 | -0.1150 | 0.0700 |
| Free Cash Flow 1 | - | -79.03 | -41 | - | - |
| FCF margin | - | -5,347.88% | -19,838.39% | - | - |
| FCF Conversion (EBITDA) | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - |
| Announcement Date | 23-04-17 | 24-04-01 | - | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 0.0111 | 0.5563 | 0.4148 | 0.0414 | 0.04 | 0.085 | 0.165 | 0.23 |
| EBITDA 1 | -5.663 | -346.8 | -4.77 | -2.42 | -1.37 | -1.27 | -1.11 | -0.97 |
| EBIT 1 | -5.764 | -347.5 | -4.84 | -4.206 | -5.1 | -5.05 | -5 | -4.95 |
| Operating Margin | -52,114.92% | -62,472.44% | -1,166.77% | -10,162.04% | -12,750% | -5,941.18% | -3,030.3% | -2,152.17% |
| Earnings before Tax (EBT) 1 | -5.668 | -347.5 | -4.535 | -3.845 | -5.2 | -5.2 | -5.2 | -0.85 |
| Net income 1 | -4.367 | -348.7 | -4.721 | -3.954 | -4.6 | -4.65 | -4.65 | -1.6 |
| Net margin | -39,488.43% | -62,694.3% | -1,138.21% | -9,553.93% | -11,500% | -5,470.59% | -2,818.18% | -695.65% |
| EPS 2 | - | -4.530 | - | -0.0500 | -0.0500 | -0.0500 | -0.0500 | -0.0250 |
| Dividend per Share | - | - | - | - | - | - | - | - |
| Announcement Date | 23-09-20 | 23-12-14 | 24-04-01 | 24-05-13 | - | - | - | - |
1USD in Million2USD
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - |
| Net Cash position 1 | - | 49.4 | 108 | 57.8 | 57.8 |
| Leverage (Debt/EBITDA) | - | - | - | - | - |
| Free Cash Flow 1 | - | -79 | -41 | - | - |
| ROE (net income / shareholders' equity) | - | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - |
| Assets 1 | - | - | - | - | - |
| Book Value Per Share | - | - | - | - | - |
| Cash Flow per Share | - | - | - | - | - |
| Capex | - | 52.1 | - | 340 | 507 |
| Capex / Sales | - | 3,522.24% | - | 21,608.9% | 16,697.82% |
| Announcement Date | 23-04-17 | 24-04-01 | - | - | - |
1USD in Million
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
7.2
USD
Average target price
14.45
USD
Spread / Average Target
+100.69%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -20.35% | 576M | |
| +56.49% | 46.59B | |
| +42.05% | 29.62B | |
| +15.62% | 14.77B | |
| +79.08% | 11.81B | |
| +38.63% | 8.39B | |
| +25.30% | 7.21B | |
| +19.23% | 6.98B | |
| +73.64% | 6.2B | |
| +41.85% | 4.51B |
- Stock Market
- Equities
- LZM Stock
- Financials Lifezone Metals Limited
